Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01409135
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Conditions: Tumors;   Medical Oncology;   Neoplasms
Interventions: Drug: AGS-22M6E;   Drug: ASG-22CE

Indicates status has not been verified in more than two years